argenx SE | Results Presentation Deck | 10 slides

argenx · 2022-04

arc beats above · slides in the middle · loops below · scroll → 0 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 10 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits

— 0/1 slides

100% 1/1 slides

— 0/1 slides

100% 1/1 slides

— 0/1 slides

Agitate 2 slides 100% 2/2 slides 100% 2/2 slides · 8 hits

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Solution 7 slides 100% 7/7 slides 100% 7/7 slides · 29 hits

— 0/7 slides

42.9% 3/7 slides 14.3% 1/7 slides 100% 7/7 slides

— 0/7 slides

every slide · same image gating as the playbook

Includes author list and institutional affiliations.front_matter

other

Includes a biological process diagram showing the interaction between Efgartigimod, FcRn, and IgG in an endothelial cell.present_solution

The slide uses a process flow diagram to illustrate the clinical trial methodology.present_framework

AChR-Ab+ population; data includes patient counts per cycle/week.analyze_data

The chart uses a back-to-back bar chart (diverging bar) format to compare two treatment groups across two different clinical metrics.analyze_data

The table displays IR/PY (Incidence Rate per Patient Year) and % (n) for various safety categories.analyze_data

The slide serves as a safety disclosure to preempt concerns regarding mortality in the clinical trial.preempt_rebuttal

The chart includes a normal distribution overlay and highlights the 5-cycle mark.analyze_data

The slide uses three distinct colored pill-shaped containers to present key findings.summarize